Jennifer L. Moran

Jennifer L. Moran

Auto-generated profile, based on publicly available information

Jennifer L. Moran

Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2014 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
GGGiulio Genovese
Giulio Genovese
AKAnna K. Kähler
Anna K. Kähler
RHRobert E. Handsaker
Robert E. Handsaker
JLJohan Lindberg
Johan Lindberg
SRSamuel A. Rose
Samuel A. Rose
SMSteven A. McCarroll
Steven A. McCarroll
Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling. Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most frequently involved somatic mutations in three genes (DNMT3A, ASXL1, and TET2) that have previously been implicated in hematologic cancers. Clonal hematopoiesis was a strong risk factor for subsequent hematologic cancer (hazard ratio, 12.9; 95% confidence interval, 5.8 to 28.7). Approximately 42% of hematologic cancers in this cohort arose in persons who had clonality at the time of DNA sampling, more than 6 months before a first diagnosis of cancer. Analysis of bone marrow–biopsy specimens obtained from two patients at the time of diagnosis of acute myeloid leukemia revealed that their cancers arose from the earlier clones. Clonal hematopoiesis with somatic mutations is readily detected by means of DNA sequencing, is increasingly common as people age, and is associated with increased risks of hematologic cancer and death. A subset of the genes that are mutated in patients with myeloid cancers is frequently mutated in apparently healthy persons; these mutations may represent characteristic early events in the development of hematologic cancers. (Funded by the National Human Genome Research Institute and others.)

25 February 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JGJakob Grove
Jakob Grove
SRStephan Ripke
Stephan Ripke
TAThomas D. Als
Thomas D. Als
MMManuel Mattheisen
Manuel Mattheisen
RWRaymond K. Walters
Raymond K. Walters
BUBupgen
Bupgen
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD.

26 November 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DDDitte Demontis
Ditte Demontis
RWRaymond K. Walters
Raymond K. Walters
JMJoanna Martin
Joanna Martin
MMManuel Mattheisen
Manuel Mattheisen
TAThomas D. Als
Thomas D. Als
BNBenjamin M. Neale
Benjamin M. Neale
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 individuals diagnosed with ADHD and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, finding important new information about the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes and around brain-expressed regulatory marks. Analyses of three replication studies: a cohort of individuals diagnosed with ADHD, a self-reported ADHD sample and a meta-analysis of quantitative measures of ADHD symptoms in the population, support these findings while highlighting study-specific differences on genetic overlap with educational attainment. Strong concordance with GWAS of quantitative population measures of ADHD symptoms supports that clinical diagnosis of ADHD is an extreme expression of continuous heritable traits.

22 January 2014 in Nature
Verified
Journal Article
Closed access
PDF file
MFMenachem Fromer
Menachem Fromer
APAndrew J. Pocklington
Andrew J. Pocklington
DKDavid H. Kavanagh
David H. Kavanagh
HWHywel Williams
Hywel Williams
SDSarah Dwyer
Sarah Dwyer
MOMichael C. O’donovan
Michael C. O’donovan

25 August 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SRStephan Ripke
Stephan Ripke
COColm O'Dushlaine
Colm O'Dushlaine
KCKimberly Chambert
Kimberly Chambert
JMJennifer L Moran
Jennifer L Moran
AKAnna K Kähler
Anna K Kähler
PSPatrick F Sullivan
Patrick F Sullivan
Patrick Sullivan and colleagues report a multi-stage genome-wide association study for schizophrenia in a Swedish population. They identify 13 loci newly associated with schizophrenia. Schizophrenia is an idiopathic mental disorder with a heritable component and a substantial public health impact. We conducted a multi-stage genome-wide association study (GWAS) for schizophrenia beginning with a Swedish national sample (5,001 cases and 6,243 controls) followed by meta-analysis with previous schizophrenia GWAS (8,832 cases and 12,067 controls) and finally by replication of SNPs in 168 genomic regions in independent samples (7,413 cases, 19,762 controls and 581 parent-offspring trios). We identified 22 loci associated at genome-wide significance; 13 of these are new, and 1 was previously implicated in bipolar disorder. Examination of candidate genes at these loci suggests the involvement of neuronal calcium signaling. We estimate that 8,300 independent, mostly common SNPs (95% credible interval of 6,300–10,200 SNPs) contribute to risk for schizophrenia and that these collectively account for at least 32% of the variance in liability. Common genetic variation has an important role in the etiology of schizophrenia, and larger studies will allow more detailed understanding of this disorder.

22 January 2014 in Nature
Verified
Journal Article
Open access
PDF file
SPShaun M. Purcell
Shaun M. Purcell
JMJennifer L. Moran
Jennifer L. Moran
MFMenachem Fromer
Menachem Fromer
DRDouglas Ruderfer
Douglas Ruderfer
NSNadia Solovieff
Nadia Solovieff
PSPamela Sklar
Pamela Sklar
Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.